Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Pappalardo, Morena ^a   Julia, Miguel ^a   Howard, Mark J ^a   Rossman, Jeremy S ^a   Michaelis, Martin ^a   Wass, Mark N ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 5, HUMAN; MATRIX PROTEIN; VIRAL PROTEIN; VIRULENCE FACTOR; VP24 PROTEIN, EBOLA VIRUS; VP40 PROTEIN, VIRUS;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CONSERVED SEQUENCE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; GENETIC VARIATION; GENETICS; HOST RANGE; HUMAN; METABOLISM; MOLECULAR MODEL; PATHOGENICITY; PHYLOGENY; PIG; PROTEIN CONFORMATION; SWINE DISEASE; TRANSMISSION; VETERINARY; VIROLOGY;

ALPHA KARYOPHERINS; AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; EBOLAVIRUS; GENETIC VARIATION; HEMORRHAGIC FEVER, EBOLA; HOST SPECIFICITY; HUMANS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN CONFORMATION; SWINE; SWINE DISEASES; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRULENCE FACTORS;

EID: 84961620816     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23743     Document Type: Article

References (63)

1. Feldmann, H., Geisbert, T. W. Ebola haemorrhagic fever. Lancet 377, 849-862 (2011).
2. Weingartl, H. M., Nfon, C., Kobinger, G. Review of Ebola virus infections in domestic animals. Dev Biol (Basel) 135, 211-218 (2013).
3. Miranda, M. E. G., Miranda, N. L. J. Reston ebolavirus in humans and animals in the Philippines: a review. J. Infect. Dis. 204 Suppl 3, S757-60 (2011).
4. Mehedi, M. et al. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J. Virol. 85, 5406-5414 (2011).
5. La Vega, de M.-A., Wong, G., Kobinger, G. P., Qiu, X. The multiple roles of sGP in Ebola pathogenesis. Viral Immunol. 28, 3-9 (2015).
6. Basler, C. F. Portrait of a killer: genome of the 2014 EBOV outbreak strain. Cell Host Microbe 16, 419-421 (2014).
7. Hoenen, T. et al. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. J. Infect. Dis. jiv111, doi: 10.1093/infdis/jiv111 (2015).
8. Zhang, A. P. P. et al. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog. 8, e1002550 (2012).
9. Bale, S. et al. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism. J. Virol. 87, 10385-10388 (2013).
10. Clifton, M. C. et al. Structure of the Reston ebolavirus VP30 C-terminal domain. Acta Crystallogr F Struct Biol Commun 70, 457-460 (2014).
11. Casari, G., Sander, C., Valencia, A. A method to predict functional residues in proteins. Nat Struct Biol 2, 171-178 (1995).
12. Rausell, A., Juan, D., Pazos, F., Valencia, A. Protein interactions and ligand binding: From protein subfamilies to functional specificity. Proc. Natl. Acad. Sci. USA 107, 1995-2000 (2010).
13. Teng, Y. et al. Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak. Sci Rep 5, 9912 (2015).
14. Chambers, J. C. et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43, 1131-1138 (2011).
15. Chambers, J. C. et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42, 373-375 (2010).
16. Chambers, J. C. et al. The South Asian genome. PLos One 9, e102645 (2014).
17. Palles, C. et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 45, 136-144 (2013).
18. Pickett, B. E. et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 40, D593-8 (2012).
19. Morikawa, S., Saijo, M., Kurane, I. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston). Comparative Immunology, Microbiology and Infectious Diseases 30, 391-398 (2007).
20. Gire, S. K. et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369-1372 (2014).
21. Liu, S.-Q., Deng, C.-L., Yuan, Z.-M., Rayner, S., Zhang, B. Identifying the pattern of molecular evolution for Zaire ebolavirus in the 2014 outbreak in West Africa. Infect Genet Evol 32, 51-59 (2015).
22. Vogel, G. Infectious Diseases. A reassuring snapshot of Ebola. Science 347, 1407-1407 (2015).
23. Hoenen, T. et al. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science 348, 117-119 (2015).
24. Xu, W., Edwards, M. R., Borek, D. M., Feagins, A. R., Mittal, A. Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1. Cell Host Microbe 13, 187-200 (2014).
25. Miller, E. H. et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31, 1947-1960 (2012).
26. Dahlmann, F. et al. Analysis of Ebola Virus Entry Into Macrophages. J. Infect. Dis. jiv140, doi: 10.1093/infdis/jiv140 (2015).
27. Herbert, A. S. et al. Niemann-pick c1 is essential for ebolavirus replication and pathogenesis in vivo. MBio 6, e00565-15 (2015).
28. Groseth, A. et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLos Pathog. 8, e1002847 (2012).
29. Yaddanapudi, K. et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 20, 2519-2530 (2006).
30. Hartlieb, B., Modrof, J., Muhlberger, E., Klenk, H.-D., Becker, S. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J. Biol. Chem. 278, 41830-41836 (2003).
31. Hartlieb, B., Muziol, T., Weissenhorn, W., Becker, S. Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc. Natl. Acad. Sci. USA 104, 624-629 (2007).
32. Leung, D. W. et al. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J. Mol. Biol. 399, 347-357 (2010).
33. Leung, D. W. et al. Structure of the Ebola VP35 interferon inhibitory domain. Proc. Natl. Acad. Sci. USA 106, 411-416 (2009).
34. Kimberlin, C. R. et al. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc. Natl. Acad. Sci. USA 107, 314-319 (2010).
35. Leung, D. W. et al. An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Rep doi: 10.1016/j.celrep.2015.03.034 (2015).
36. Bornholdt, Z. A. et al. Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell 154, 763-774 (2013).
37. Mateo, M. et al. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication. J. Infect. Dis. 204 Suppl 3, S892-6 (2011).
38. Mateo, M. et al. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. J. Infect. Dis. 204 Suppl 3, S1011-20 (2011).
39. Watt, A. et al. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J. Virol. 88, 10511-10524 (2014).
40. Reid, S. P. et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80, 5156-5167 (2006).
41. Reid, S. P., Valmas, C., Martinez, O., Sanchez, F. M., Basler, C. F. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 81, 13469-13477 (2007).
42. Zhang, A. P. P. et al. The ebolavirus VP24 interferon antagonist: know your enemy. Virulence 3, 440-445 (2012).
43. Ilinykh, P. A. et al. Different temporal effects of Ebola virus VP35 and VP24 proteins on the global gene expression in human dendritic cells. J. Virol. JVI. 00924-15, doi: 10.1128/JVI.00924-15 (2015).
44. Volchkov, V. E., Chepurnov, A. A., Volchkova, V. A., Ternovoj, V. A., Klenk, H. D. Molecular characterization of guinea pigadapted variants of Ebola virus. Virology 277, 147-155 (2000).
45. Ebihara, H. et al. Molecular determinants of Ebola virus virulence in mice. PLos Pathog. 2, e73 (2006).
46. Dowall, S. D. et al. Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biol. 15, 540 (2014).
47. Barrette, R. W. et al. Discovery of swine as a host for the Reston ebolavirus. Science 325, 204-206 (2009).
48. Marsh, G. A. et al. Ebola Reston virus infection of pigs: clinical significance and transmission potential. J. Infect. Dis. 204 Suppl 3, S804-9 (2011).
49. Akerlund, E., Prescott, J., Tampellini, L. Shedding of Ebola Virus in an Asymptomatic Pregnant Woman. N. Engl. J. Med. 372, 2467-2469 (2015).
50. Kuhn, J. H. et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Archives of Virology 155, 2083-2103 (2010).
51. Rice, P., Longden, I., Bleasby, A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16, 276-277 (2000).
52. Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).
53. Mistry, J. et al. Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions Nucleic Acids Res. 41, e121 (2013).
54. UniProt Consortium. Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42, D191-8 (2014).
55. Bouckaert, R. et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput. Biol. 10, e1003537 (2014).
56. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312-1313 (2014).
57. Paradis, E., Claude, J., Strimmer, K. APE: Analyses of Phylogenetics and Evolution in R language. Bioinformatics 20, 289-290 (2004).
58. Rose, P. W. et al. The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res. 43, D345-56 (2015).
59. Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., Sternberg, M. J. E. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10, 845-858 (2015).
60. Joosten, R. P. et al. A series of PDB related databases for everyday needs. Nucleic Acids Res. 39, D411-9 (2011).
61. Smith, N. et al. DelPhi web server v2: incorporating atomic-style geometrical figures into the computational protocol. Bioinformatics 28, 1655-1657 (2012).
62. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612 (2004).
63. Pires, D. E. V., Ascher, D. B., Blundell, T. L. mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics 30, 335-342 (2014).